Financials

  • Market Capitalization 68.99 M
  • Employee 5
  • Founded 2005
  • CEO N/A
  • Website www.neonc.com
  • Headquarter Delaware, United States
  • FIGI BBG01KPDB522
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.58
Rapporto prezzo/fatturato
4 011.7

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4019
CING
Cingulate Inc. - Common Stock
4.78 USD-1.24%-2.25%-4.40%-22.40%69.51 M USD
4025
XBIT
XBiotech Inc. - Common Stock
2.26 USD-0.44%+4.63%+2.73%-11.37%68.90 M USD
4033
CSBR
Champions Oncology, Inc. - Common Stock
4.87 USD-1.62%-0.61%-2.79%-24.85%67.78 M USD
4039
SPRO
Spero Therapeutics, Inc. - Common Stock
1.16 USD-1.69%-4.13%+2.65%-48.21%67.55 M USD